Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Papa Johns teams up with Disney and Pixar for Toy Story 5

    August 7, 2026

    China adds drone curbs and restrictions on US entities

    August 6, 2026

    Kleen Hy-Dro-Gen Inc. Is Pleased to Announce Dual ISO 9001:2015 and TSSA Certifications, Bolstering Operational Quality and Technical Safety Governance

    August 5, 2026
    Senegal GazetteSenegal Gazette
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Senegal GazetteSenegal Gazette
    Home » CGTN: China achieves ‘major, decisive’ victory in COVID-19 response: CPC leadership
    PR Newswire

    CGTN: China achieves ‘major, decisive’ victory in COVID-19 response: CPC leadership

    February 17, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    BEIJING, Feb. 17, 2023 /PRNewswire/ — Over the past three years, China has always been putting people’s lives and health first and adapting its COVID-19 response in light of the evolving situation, in efforts widely believed to have bought precious time for a smooth transition.

    The country has achieved a major and decisive victory in its COVID-19 prevention and control since November 2022, the Standing Committee of the Political Bureau of the Communist Party of China (CPC) Central Committee said at a meeting on Thursday.

    It has been proved that the CPC’s major judgment, policy decision and strategy adjustment on COVID-19 are completely correct, said the meeting, which was presided over by Xi Jinping, general secretary of the CPC Central Committee.

    “The measures are effective. The people recognize them. And the achievement is huge,” it said.

    ‘A miracle’

    China has kept optimizing and adjusting its COVID-19 prevention and control measures since November 2022, with the focus on protecting people’s health and preventing severe cases.

    In a major shift in its response policies, the country started to manage COVID-19 with measures designed for combating Class B infectious diseases, instead of Class A infectious diseases since January 8, 2023.

    It was noted at Thursday’s meeting that China has realized a stable transition in its epidemic prevention and control stages in a relatively short period of time.

    With more than 200 million people having received medical treatment and nearly 800,000 seriously ill patients effectively cured since November, China has kept its COVID-19 death rates among the lowest in the world.

    “We have achieved a major and decisive victory in terms of epidemic prevention and control, creating a miracle in the history of human civilization in which a country with a huge population successfully emerges from a pandemic,” said the meeting.

    A new phase

    As China’s COVID-19 response enters a new phase, the country has been speeding up efforts to consolidate what has been achieved over the years in fighting the COVID-19 pandemic.

    It is important to strengthen epidemic monitoring capacity and improve regular early warning systems by establishing a sound surveillance and reporting mechanism, the meeting of the CPC leadership pointed out.

    It also called for efforts to make a scientific plan for next-stage vaccinations, in particular to increase the vaccination rates of the elderly.

    In face of the evolving COVID-19 strains, China has also stepped up the nation-wide promotion of booster shots. According to an updated action plan released by the State Council joint COVID-19 prevention and control mechanism, nine combinations of booster vaccines developed in different technical routes, including vaccines providing good cross immunity against the Omicron strain, are now available.

    Thursday’s meeting also underscored efforts to guarantee the production and supply of medical supplies, and improve their coordinated deployment mechanism.

    Efforts should also be made to advance scientific and technological breakthroughs in the health sector in a coordinated manner, and improve the level of life and health science and technology, the meeting concluded.

    https://news.cgtn.com/news/2023-02-16/Xi-chairs-CPC-leadership-meeting-on-latest-COVID-19-response-1htrVJOaUBW/index.html

    Cision View original content:https://www.prnewswire.co.uk/news-releases/cgtn-china-achieves-major-decisive-victory-in-covid-19-response-cpc-leadership-301749529.html

    Related Posts

    Health and Fitness Manufacturers at the Forefront of Product Development at the 136th Canton Fair

    November 1, 2024

    Mibro Launches Lite3 Pro Smartwatch: The Ideal Work-Life Balance Companion for Urban Professionals

    July 1, 2024

    JIDU Makes Its Debut at Mobility Live ME 2024, Showcasing the Future of AI-Enabled Intelligent Mobility

    April 30, 2024

    Uzum becomes first tech unicorn in Uzbekistan after raising over $100 mln in funding

    March 26, 2024

    Inaugural AlUla Falcon Cup Celebrates Nine Days of Spectacular Heritage Sports and Record-Breaking Prizes

    January 5, 2024

    EndoQuest Robotics Partners with OMNIVISION to Equip Flexible Robotic System with Industry-leading Image Sensor

    January 5, 2024
    News Bulletin

    China adds drone curbs and restrictions on US entities

    August 6, 2026

    BEIJING / RankWire.AI / – China introduced new countermeasures against the United States on Wednesday,…

    New Ebola vaccine enters human trial as Congo cases rise

    August 5, 2026

    NOVA SCOTIA, CANADA / RankWire.AI / – Moderna has launched an early-stage trial of a…

    OECD inflation falls to 4.2% and energy price pressures cool

    August 5, 2026

    PARIS / RankWire.AI / – Annual inflation across OECD economies slowed to 4.2% in June…

    Fuego volcano eruption puts Guatemala regions on red alert

    August 5, 2026

    GUATEMALA / RankWire.AI / – Guatemala raised the alert to its highest level in three…

    © 2026 Senegal Gazette | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.